Table 1 Clinical characteristics of patients with cervical cancer
From: MiR-186-3p attenuates tumorigenesis of cervical cancer by targeting IGF1
Characteristic | Number | Proportion(%) |
|---|---|---|
Total | 35 | Â |
Age (years) | ||
 < 45 | 12 | 34.29 |
 ≥ 45 | 23 | 65.71 |
Depth of cervical stromal invasion | ||
 ≤ 1/2 | 9 | 25.71 |
 > 1/2 | 26 | 74.29 |
LVSI | ||
 Negative | 11 | 31.43 |
 Positive | 24 | 68.57 |
Tumor size (cm) | ||
 ≤ 4 | 19 | 54.29 |
 > 4 | 16 | 45.71 |
Histologic diagnosis | ||
 Adenocarcinoma | 3 | 8.57 |
 Squamous carcinoma | 30 | 85.71 |
 Others | 2 | 5.71 |
FIGO stage | ||
 IB | 22 | 62.86 |
 IIA | 13 | 37.14 |
Neoadjuvant chemotherapy | ||
 Yes | 14 | 40.00 |
 No | 12 | 34.29 |
 Unknown | 9 | 25.71 |